|
1) Costa D, Poeta P, Saenz Y, et al. Mechanisms of antibiotic resistance in Escherichia coli isolates recovered from wild animals. Microb Drug Resist. 2008; 14: 71-7
|
|
|
|
2) Delsol AA, Halfhide DE, Bagnall MC, et al. Persistence of a wild type Escherichia coli and its multiple antibiotic-resistant (MAR) derivatives in the abattoir and on chilled pig carcasses. Int J Food Microbiol. 2011; 140: 249-53
|
|
|
|
|
|
3) Leflon-Guibout V, Blanco J, Amaqdouf K, et al. Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France. J Clin Microbiol. 2008; 46: 3900-5
|
|
|
|
|
|
4) Bush K, Jacoby GA. Updated functional classification of β-lactamases. Antimicrob Agents Chemother. 2010; 54: 969-76
|
|
|
|
|
|
5) Queenan AM, Bush K. Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev. 2007; 20: 440-58, table of contents
|
|
|
|
|
|
6) Alekshun MN, Levy SB. Molecular mechanisms of antibacterial multidrug resistance. Cell. 2007; 128: 1037-50
|
|
|
|
|
|
7) Laraki N, Franceschini N, Rossolini GM, et al. Biochemical characterization of the Pseudomonas aeruginosa 101/1477 metallo-β-lactamase IMP-1 produced by Escherichia coli. Antimicrob Agents Chemother. 1999; 43: 90290-6
|
|
|
|
|
|
8) Yong D, Toleman MA, Giske CG, et al. Characterization of a new metallo-beta-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 2009; 53: 5046-54
|
|
|
|
|
|
9) Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010; 10: 597-602
|
|
|
|
|
|
10) Ho PL, Lo WU, Yeung MK, et al. Complete sequencing of pNDM-HK encoding NDM-1 carbapenemase from a multidrug-resistant Escherichia coli strain isolated in Hong Kong. PLoS One. 2011; 6: e17989
|
|
|
|
|
|
11) Foster GC, McGhee GC, Jones AL, et al. Nucleotide sequences, genetic organization, and distribution of pEU30 and pEL60 from Erwinia amylovora. Appl Environ Microbiol. 2004; 70: 7539-44
|
|
|
|
|
|
12) Golebiewski M, Kern-Zdanowicz I, Zienkiewicz M, et al. Complete nucleotide sequence of the pCTX-M3 plasmid and its involvement in spread of the extended-spectrum β-lactamase gene blaCTX-M-3. Antimicrob Agents Chemother. 2007; 51: 3789-95
|
|
|
|
|
|
13) Zhu WH, Luo L, Wang JY, et al. Complete nucleotide sequence of pCTX-M360, an intermediate plasmid between pEL60 and pCTX-M3, from a multidrug-resistant Klebsiella pneumoniae strain isolated in China. Antimicrob Agents Chemother. 2009; 53: 5291-3
|
|
|
|
|
|
14) Walsh TR, Weeks J, Livermore DM, et al. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis. 2011; 3099: in press
|
|
|
|
|
|
15) Castanheira M, Deshpande LM, Mathai D, et al. Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006-2007. Antimicrob Agents Chemother. 2011; 55: 1274-8
|
|
|
|
|
|
16) Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; Twentieth one informational supplement. Vol. M100-S21. Wayne, PA: Clinical and Laboratory Standards Institute. 2011
|
|
|
|
|
|
17) Poirel L, Lagrutta E, Taylor P, et al. Emergence of metallo-β-lactamase NDM-1-producing multidrug-resistant Escherichia coli in Australia. Antimicrob Agents Chemother. 2010; 54: 4914-6
|
|
|
|
|
|
18) Falagas ME, Maraki S, Karageorgopoulos DE, et al. Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin. Int J Antimicrob Agents. 2010; 35: 240-3
|
|
|
|
|
|
19) Souli M, Galani I, Antoniadou A, et al. An outbreak of infection due to β-lactamase Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes. Clin Infect Dis. 2011; 50: 364-73
|
|
|
|
|
|
20) Falagas ME, Kastoris AC, Kapaskelis AM, et al. Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review. Lancet Infect Dis. 2010; 10: 43-50
|
|
|
|
|
|
21) Oteo J, Orden B, Bautista V, et al. CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin. J Antimicrob Chemother. 2009; 64: 712-7
|
|
|
|
|
|
22) Poirel L, Al Maskari Z, Al Rashdi F, et al. NDM-1-producing Klebsiella pneumoniae isolated in the Sultanate of Oman. J Antimicrob Chemother. 2011; 66: 304-6
|
|
|
|
|
|
23) Chen Y, Zhou Z, Jiang Y, et al. Emergence of NDM-1-producing Acinetobacter baumannii in China. J Antimicrob Chemother. 2011; 66: 1255-9
|
|
|
|
|
|
24) Kaase M, Nordmann P, Wichelhaus TA, et al. NDM-2 carbapenemase in Acinetobacter baumannii from Egypt. J Antimicrob Chemother. 2011; 66: 1260-2
|
|
|
|
|